Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells have?
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells has 23 citations in the OpenAlex counts ScholarIQ stores.
When was Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells published?
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells has 2020 year in the ScholarIQ index.
What is the open-access status of Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells?
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells has hybrid oa status in the ScholarIQ index.
What is the DOI of Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells?
The DOI for Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells is on the source record.
What is the PMID of Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells?
The PMID for Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells is on the source record.
What is the OpenAlex record for Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells?
The OpenAlex for Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells is on the source record.